The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
784
January 27, 1989
View Complete Issue         Table of Contents 2019 
Tiopronin for Cystinuria
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Tiopronin for Cystinuria
January 27, 1989 (Issue: 784)
Tiopronin (Thiola - Mission), a thiol compound (mercaptopropionyl glycine) that solubilizes cystine by reacting with it to form a mixed disulfide, is now available in the USA for treatment of refractory cystinuria.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Tiopronin for Cystinuria
Article code: 784c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.